<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The telomeropathies are a newly described group of human diseases based on the genetics and molecular biology of the telomeres, the ends of chromosomes </plain></SENT>
<SENT sid="1" pm="."><plain>Telomeres are repeated hexanucleotides and their associated proteins; the protect chromosomes from recognition as damaged DNA, and their inevitable gradual loss with DNA replication is harmless as they are noncoding </plain></SENT>
<SENT sid="2" pm="."><plain>However, when telomeres become critically short in a cell, senescence, <z:mpath ids='MPATH_3'>apoptosis</z:mpath>, or, rarely <z:e sem="disease" ids="C1608408" disease_type="Neoplastic Process" abbrv="">malignant transformation</z:e> results </plain></SENT>
<SENT sid="3" pm="."><plain>In individuals with mutations in genes involved in telomere repair, especially the enzymatic telomerase complex, telomere attrition is accelerated </plain></SENT>
<SENT sid="4" pm="."><plain>Severe deficiencies result in <z:mp ids='MP_0009563'>dyskeratosis</z:mp> congenita, a congenital <z:hpo ids='HP_0001915'>aplastic anemia</z:hpo> with associated mucocutaneous abnormalities </plain></SENT>
<SENT sid="5" pm="."><plain>Mutations in TERT, the catalytic component, and TERC, the <z:chebi fb="40" ids="33697">RNA</z:chebi> template, can behave as risk factors for the development of <z:hpo ids='HP_0005528'>bone marrow failure</z:hpo>, <z:hpo ids='HP_0002206'>pulmonary fibrosis</z:hpo>, and <z:hpo ids='HP_0001394'>hepatic cirrhosis</z:hpo> </plain></SENT>
<SENT sid="6" pm="."><plain>Both penetrance and organ specificity are variable and not well understood </plain></SENT>
<SENT sid="7" pm="."><plain>Chromosome instability is a result of critical shortening of telomeres and <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> </plain></SENT>
<SENT sid="8" pm="."><plain>For example, short telomeres are the major prognostic risk factor for <z:e sem="disease" ids="C1516669" disease_type="Neoplastic Process" abbrv="">clonal evolution</z:e> to <z:hpo ids='HP_0002863'>myelodysplasia</z:hpo> and <z:hpo ids='HP_0002488'>acute leukemia</z:hpo> </plain></SENT>
<SENT sid="9" pm="."><plain>Practically, hematologists need to recognize the multisystem presentation of telomere disease, implications for outcomes, and options for therapy </plain></SENT>
</text></document>